Form 8-K - Current report:
SEC Accession No. 0001213900-25-089584
Filing Date
2025-09-19
Accepted
2025-09-19 16:38:18
Documents
22
Period of Report
2025-09-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0258026-8k_jasper.htm   iXBRL 8-K 53815
2 UNDERWRITING AGREEMENT, DATED AS OF SEPTEMBER 18, 2025, BY AND BETWEEN JASPER TH ea025802601ex1-1_jasper.htm EX-1.1 293075
3 FORM OF PRE-FUNDED WARRANT TO PURCHASE COMMON STOCK ea025802601ex4-1_jasper.htm EX-4.1 93323
4 FORM OF COMMON WARRANT ea025802601ex4-2_jasper.htm EX-4.2 104010
5 OPINION OF PAUL HASTINGS LLP ea025802601ex5-1_jasper.htm EX-5.1 9228
6 PRESS RELEASE, DATED SEPTEMBER 18, 2025 ea025802601ex99-1_jasper.htm EX-99.1 11736
7 GRAPHIC ex5-1_001.jpg GRAPHIC 3339
8 GRAPHIC ex5-1_002.jpg GRAPHIC 8771
9 GRAPHIC ex5-1_003.jpg GRAPHIC 2494
10 GRAPHIC ex99-1_001.jpg GRAPHIC 11439
  Complete submission text file 0001213900-25-089584.txt   951017

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE jspr-20250918.xsd EX-101.SCH 3897
12 XBRL DEFINITION FILE jspr-20250918_def.xml EX-101.DEF 26812
13 XBRL LABEL FILE jspr-20250918_lab.xml EX-101.LAB 37092
14 XBRL PRESENTATION FILE jspr-20250918_pre.xml EX-101.PRE 25436
24 EXTRACTED XBRL INSTANCE DOCUMENT ea0258026-8k_jasper_htm.xml XML 5987
Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Filer) CIK: 0001788028 (see all company filings)

EIN.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39138 | Film No.: 251327306
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)